796 related articles for article (PubMed ID: 16511588)
1. Estrogen receptors and human disease.
Deroo BJ; Korach KS
J Clin Invest; 2006 Mar; 116(3):561-70. PubMed ID: 16511588
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice.
Mueller SO; Korach KS
Curr Opin Pharmacol; 2001 Dec; 1(6):613-9. PubMed ID: 11757817
[TBL] [Abstract][Full Text] [Related]
3. Lessons from the dissection of the activation functions (AF-1 and AF-2) of the estrogen receptor alpha in vivo.
Arnal JF; Fontaine C; Abot A; Valera MC; Laurell H; Gourdy P; Lenfant F
Steroids; 2013 Jun; 78(6):576-82. PubMed ID: 23200732
[TBL] [Abstract][Full Text] [Related]
4. The Case for an Estrogen-iron Axis in Health and Disease.
Hamad M; Bajbouj K; Taneera J
Exp Clin Endocrinol Diabetes; 2020 Apr; 128(4):270-277. PubMed ID: 30978727
[TBL] [Abstract][Full Text] [Related]
5. Estrogen(s) and analogs as a non-immunogenic endogenous ligand in targeted drug/DNA delivery.
Rai S; Paliwal R; Vaidya B; Gupta PN; Mahor S; Khatri K; Goyal AK; Rawat A; Vyas SP
Curr Med Chem; 2007; 14(19):2095-109. PubMed ID: 17691950
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptors and human disease: an update.
Burns KA; Korach KS
Arch Toxicol; 2012 Oct; 86(10):1491-504. PubMed ID: 22648069
[TBL] [Abstract][Full Text] [Related]
7. Aging and age-related diseases--from endocrine therapy to target therapy.
Bao Q; Pan J; Qi H; Wang L; Qian H; Jiang F; Shao Z; Xu F; Tao Z; Ma Q; Nelson P; Hu X
Mol Cell Endocrinol; 2014 Aug; 394(1-2):115-8. PubMed ID: 25038521
[TBL] [Abstract][Full Text] [Related]
8. Special issue: RNA biology in physiology and disease.
Kretz M; Medenbach J; Meister G
Pflugers Arch; 2016 Jun; 468(6):933-4. PubMed ID: 27178287
[No Abstract] [Full Text] [Related]
9. [Estrogen receptor gene polymorphism].
Hoshino S; Inoue S; Ouchi Y
Nihon Rinsho; 2002 Mar; 60 Suppl 3():111-9. PubMed ID: 11979896
[No Abstract] [Full Text] [Related]
10. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators.
Härkönen PL; Väänänen HK
Ann N Y Acad Sci; 2006 Nov; 1089():218-27. PubMed ID: 17261769
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor beta in health and disease.
Imamov O; Shim GJ; Warner M; Gustafsson JA
Biol Reprod; 2005 Nov; 73(5):866-71. PubMed ID: 16033996
[TBL] [Abstract][Full Text] [Related]
12. Role of estrogen receptors in pro-oxidative and anti-oxidative actions of estrogens: a perspective.
Kumar S; Lata K; Mukhopadhyay S; Mukherjee TK
Biochim Biophys Acta; 2010 Oct; 1800(10):1127-35. PubMed ID: 20434525
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes.
Korach KS; Couse JF; Curtis SW; Washburn TF; Lindzey J; Kimbro KS; Eddy EM; Migliaccio S; Snedeker SM; Lubahn DB; Schomberg DW; Smith EP
Recent Prog Horm Res; 1996; 51():159-86; discussion 186-8. PubMed ID: 8701078
[TBL] [Abstract][Full Text] [Related]
14. The role of the estrogen in neuroprotection: implications for neurodegenerative diseases.
Cho JJ; Iannucci FA; Fraile M; Franco J; Alesius TN; Stefano GB
Neuro Endocrinol Lett; 2003; 24(3-4):141-7. PubMed ID: 14523347
[TBL] [Abstract][Full Text] [Related]
15. Antiestrogens specifically up-regulate bone morphogenetic protein-4 promoter activity in human osteoblastic cells.
van den Wijngaard A; Mulder WR; Dijkema R; Boersma CJ; Mosselman S; van Zoelen EJ; Olijve W
Mol Endocrinol; 2000 May; 14(5):623-33. PubMed ID: 10809227
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and its receptors in cancer.
Chen GG; Zeng Q; Tse GM
Med Res Rev; 2008 Nov; 28(6):954-74. PubMed ID: 18642351
[TBL] [Abstract][Full Text] [Related]
17. Structure-function relationship of estrogen receptors in cardiovascular pathophysiological models.
Arnal JF; Valéra MC; Payrastre B; Lenfant F; Gourdy P
Thromb Res; 2012 Oct; 130 Suppl 1():S7-11. PubMed ID: 23026669
[TBL] [Abstract][Full Text] [Related]
18. Phytoestrogens and their effects.
Sirotkin AV; Harrath AH
Eur J Pharmacol; 2014 Oct; 741():230-6. PubMed ID: 25160742
[TBL] [Abstract][Full Text] [Related]
19. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
[TBL] [Abstract][Full Text] [Related]
20. Editorial: Non-coding RNA in aging and age-associated diseases - from intracellular regulators to hormone like actions.
Hackl M; Suh Y; Grillari J
Mech Ageing Dev; 2017 Dec; 168():1-2. PubMed ID: 29246368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
